Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Key facts

Sponsor

International Vaccine Institute

Principal Investigator

Zulfiqar A Bhutta, MBBS, PhD

Aga Khan University

Intervention

Typhoid Vi vaccine(biological)

Enrollment

27231 enrolled

Eligibility

2-16 years · All sexes

Timeline

2001 – 2007

Study locations (1)

• Aga Khan University, Karachi, Pakistan

Collaborators

Aga Khan University · Wellcome Trust · University of Western Ontario, Canada · GlaxoSmithKline

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Paratyphoid fever

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT07314281
  Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
  Indus Hospital and Health Network
• RECRUITINGNCT04878549
  Transcriptomic Responses for the Identification of Pathogens
  University of Sheffield

See all trials for Paratyphoid fever →